UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014176
Receipt number R000016451
Scientific Title The Effects of Predilation with Scoring Balloon Compared to Conventional Balloon on Everolimus-eluting Stent Expansion Analyzed with Optical Coherent Tomography
Date of disclosure of the study information 2014/06/06
Last modified on 2015/10/10 22:55:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Effects of Predilation with Scoring Balloon Compared to Conventional Balloon on Everolimus-eluting Stent Expansion Analyzed with Optical Coherent Tomography

Acronym

Scoring Compared to Conventional Ballooning on Everolimus-eluting Stent Expansion

Scientific Title

The Effects of Predilation with Scoring Balloon Compared to Conventional Balloon on Everolimus-eluting Stent Expansion Analyzed with Optical Coherent Tomography

Scientific Title:Acronym

Scoring Compared to Conventional Ballooning on Everolimus-eluting Stent Expansion

Region

Japan


Condition

Condition

Coronary artery disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Stent expansion remains one of important predictors of restenosis and subacute thrombosis, even in use of the drug-eluting stent. In those patients, the role of different predilation strategies has yet to be established. Moreover, in the bioresorbable vascular scaffold era, sufficient lesion preparation is essential for their appropriate apposition. The aim of this study was to clarify the impact of lesion preparation using the scoring balloon on final stent expansion.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Rate of achieved to predicted stent area after deployment measured by optical coherent tomography (OCT)

Key secondary outcomes

i) Binary stent restenosis at remote phase (QCA)
ii) Target vessel diameter/area after balloon angioplasty (OCT)
iii) All-cause mortality, MACE (Major Adverse Cardiac Event)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Non-calcified coronary artery atherosclerotic lesions (calcification <50% of circumference) predilated with semi-compliant conventional balloon followed by a single 2.5-3.0 mm Cobalt-chromium Everolimus-eluting stent deployment under optical coherent tomography (OCT) guidance without post-stenting dilation.

Interventions/Control_2

Non-calcified coronary artery atherosclerotic lesions (calcification <50% of circumference) predilated with semi-compliant Scoring balloon followed by a single 2.5-3.0 mm Cobalt-chromium Everolimus-eluting stent deployment under optical coherent tomography (OCT) guidance without post-stenting dilation.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Consecutive patients undergoing staged PCI in a single cardiovascular center.
(i) Referential vessel diameter estimated by OCT ((prox.+dist.)/2): 2.5-3.0 mm
(ii) Lesion that is able to be covered by a single stent
(iii) Lesion with calcification less than 50% of circumference

Key exclusion criteria

(i) Acute coronary syndrome
(ii) Pregnant patients
(iii) Patients with malignant neoplasm whose life expectancies of less than 6 months
(iv) Patients underwent prior PCI/CABG within 6 months
(v) Patients with decompensated heart failure
(vi) Patients with chronic kidney disease > stage 4
(vii) Patients with allergic reaction against ASA or clopidogrel

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kentaro Jujo

Organization

Nishiarai Heart Center Hospital

Division name

Department of Cardiology

Zip code


Address

1-12-8, Nishiarai Honcho, Adachi-ku, Tokyo, Japan

TEL

+81358380730

Email

juken1123@hotmail.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kentaro Jujo

Organization

Nishiarai Heart Center Hospital

Division name

Department of Cardiology

Zip code


Address

1-12-8, Nishiarai Honcho, Adachi-ku, Tokyo, Japan

TEL

+81358380730

Homepage URL


Email

juken1123@hotmail.co.jp


Sponsor or person

Institute

Nishiarai Heart Center Hospital

Institute

Department

Personal name



Funding Source

Organization

Nishiarai Heart Center Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 01 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 06 Month 05 Day

Last modified on

2015 Year 10 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016451


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name